Mumbai-based Nutraceutical healthcare company Onelife Nutriscience Pvt Ltd has raised an undisclosed amount of funding from India’s leading pharmaceutical manufacturer Lasons India helmed by Mr Nevin Aggarwal, director at Lasons.
Lasons is one of the leading producers of Vitamin B3 (Niacin & Niacinamide) and specialty chemicals from India with exports to more than 100 countries including China.
On behalf of Lasons India Pvt Ltd, Mr Nevin Aggarwal said :“Onelife is a fast growing consumer healthcare brand focusing on preventive healthcare which is a growing market and need of the hour too. Covid has changed the consumer outlook towards good health and immunity and these are categories of focus for Onelife as well. Onelife is a good fit for us given the fact we are manufacturers of Vitamin B3 (API) and we understand the requirements of the consumers globally. We look forward to walking this road with Onelife and will partner with them on this journey in more ways than one.”
Onelife Nutriscience, which owns the consumer healthcare brand Onelife has raised funds from Lasons India yet again along with a successful round of funding with Wipro Consumer Care Ventures this year. Onelife which launched in 2019 today has over 100 products in the nutrition, wellness and beauty space with presence in more than 15 cities across West and North India as well as online. Onelife is geared up for its next level of growth post this round of capital. It will leverage the infused funds for geographical expansion, online & offline expansion, marketing and team building.
Onelife has a diverse set of offerings focusing on wellness, immunity, and overall nutraceutical segment. The company will use the funds for its next level of growth.